Previous close | 7.20 |
Open | 7.24 |
Bid | 7.19 x 0 |
Ask | 7.20 x 0 |
Day's range | 7.17 - 7.29 |
52-week range | 5.75 - 8.04 |
Volume | |
Avg. volume | 125,333 |
Market cap | 600.363M |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | 17.56 |
EPS (TTM) | 0.41 |
Earnings date | 12 Aug 2024 |
Forward dividend & yield | 0.48 (6.67%) |
Ex-dividend date | 28 June 2024 |
1y target est | 8.33 |
MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2024 after market close on Monday, August 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Tuesday, August 13, 2024, at 11:30 a.m. (ET) to discuss the results. To part
MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,159,997 of its common shares (the “Common Shares”), representing 10% of its public float of issued and outstanding Common Shares. As at June 18, 2024, there were 83,466,97
The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend on the 15th of July, with investors...